(Q46661250)

24 December 2017

title

Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats (English)

1 reference

24 December 2017

author name string

Katari A Carello

1

1 reference

24 December 2017

Steven E Whitesall

2

1 reference

24 December 2017

Mary C Lloyd

3

1 reference

24 December 2017

Scott S Billecke

4

1 reference

24 December 2017

Louis G D'Alecy

5

1 reference

24 December 2017

publication date

19 August 2005

1 reference

24 December 2017

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

24 December 2017

volume

290

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

H209-16

1 reference

24 December 2017

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Partial ureteral obstruction dysregulates the renal renin-angiotensin system in the fetal sheep kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Asymmetrical dimethylarginine: the Uber marker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Does ADMA cause endothelial dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Renin dependence of captopril-induced drinking after ureteric ligation in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Stimulation of endogenous nitric oxide pathway by L-arginine reduces declamp mortality and attenuates hypertension associated with aortic cross-clamp-induced hindlimb ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

An enzyme hydrolyzing methylated inhibitors of nitric oxide synthase is present in circulating human red blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Subpressor dose asymmetric dimethylarginine modulates renal function in humans through nitric oxide synthase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Structural and functional characterization of the Zn(II) site in dimethylargininase-1 (DDAH-1) from bovine brain. Zn(II) release activates DDAH-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Biological significance of endogenous methylarginines that inhibit nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Angiotensin II stimulates system y+ and cationic amino acid transporter gene expression in cultured vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Studies on the catabolism of NG-methylarginine, NG, NG-dimethylarginine and NG, NG-dimethylarginine in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Ultrastructure, renin status, contractile and electrophysiological properties of the afferent glomerular arteriole in the rat hydronephrotic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Endogenous asymmetrical dimethylarginine and hypertension associated with puromycin nephrosis in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

The human liver clears both asymmetric and symmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

The transplanted liver graft is capable of clearing asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Dimethylarginines in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Induction of L-arginine transport and nitric oxide synthase in vascular smooth muscle cells: synergistic actions of pro-inflammatory cytokines and bacterial lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

The effects of food and drink on the survival of binephrectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

Circulating angiotensin II and adrenal receptors after nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2005

10.1152/AJPHEART.00208.2005

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017